Clinical studies for a therapy for Duchenne muscular dystrophy have begun at Sirius University and the Russian biotech business Generium. At a gathering at Novosibirsk State University, Dmitry Kudlai, a Member of the Russian Academy of Sciences, offered his perspectives.
There is no clinical trial information for the Duchenne muscular dystrophy gene therapy in the Russian State Drug Register yet. As DMD Warrior, we will be following these statements.
- Follow Us -
